MRP Capital Investments’s AbbVie ABBV Stock Holding History

MRP Capital Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$129K	Hold	512	–	–	0.1%	100
2026 Q1	$111K	Hold	512	–	–	0.1%	95
2025 Q4	$117K	Sell	512 -50	-9%	-$11.4K	0.1%	107
2025 Q3	$104K	Hold	562	–	–	0.09%	116
2025 Q2	$104K	Hold	562	–	–	0.07%	102
2025 Q1	$118K	Hold	562	–	–	0.11%	109
2024 Q4	$99.9K	Hold	562	–	–	0.09%	107
2024 Q3	$111K	Buy	+562	New	+$105K	0.11%	107
2023 Q3	–	Sell	-662	Closed	-$89.2K	–	93
2023 Q2	$89.2K	Hold	662	–	–	0.09%	131
2023 Q1	$106K	Sell	662 -1,905	-74%	-$291K	0.12%	105
2022 Q4	$415K	Buy	+2,567	New	+$394K	0.46%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MRP Capital Investments's ABBV Position: Q2 2026 in Review

MRP Capital Investments held its AbbVie (ABBV) position steady in Q2 2026 at 512 shares worth $129K. The position accounts for 0.1% of the portfolio, ranked #100.

MRP Capital Investments first reported a position in ABBV in Q4 2022 and has held it in 11 quarters since. The position peaked at $415K in Q4 2022. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MRP Capital Investments held 512 shares of AbbVie worth $129K as of Q2 2026.
MRP Capital Investments left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.1% of MRP Capital Investments's portfolio in Q2 2026, its #100 holding.
MRP Capital Investments first reported a position in AbbVie in Q4 2022 and has held it in 11 quarters since.
MRP Capital Investments's AbbVie position peaked at $415K in Q4 2022.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.